Imunon, Inc. Increase (Decrease) in Prepaid Expense
Imunon, Inc. (IMNN) reported Increase (Decrease) in Prepaid Expense of $291.37 thousand for the 3-month period ending 2013-03-31, per its 10-Q filed 2013-05-09.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidExpense · last filed 2013-05-09
- Imunon, Inc. increase (decrease) in prepaid expense for the quarter ending 2013-03-31 was $291.37K.
- Imunon, Inc. increase (decrease) in prepaid expense for the quarter ending 2012-09-30 was $60.52K.
| Period end | Increase (Decrease) in Prepaid Expense 3 month | Increase (Decrease) in Prepaid Expense 6 month | Increase (Decrease) in Prepaid Expense 9 month |
|---|---|---|---|
| 2013-03-31 | $291.37K 10-Q · filed 2013-05-09 | ||
| 2012-09-30 | $60.52K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-09 | $207.21K 10-Q · filed 2012-11-09 | |
| 2012-06-30 | $146.68K 10-Q · filed 2012-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |